The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/16261
StudyName: Eligibility Breast Cancer NCT00193115
Date of export from the portal: 02.07.2020
Date of Upload / last change: 08.07.2016
License: Creative Commons BY 4.0

----

Description: 
Docetaxel Followed by Doxorubicin Plus Cyclophosphamide for Node Positive or High-Risk Primary Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00193115
